mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |